Outsourcing Trends of R&D Life Cycle Management (LCM) Activities for Biological Products in Europe

CHALLENGE

A private equity firm engaged a boutique consulting firm to investigate outsourcing trends in R&D life cycle management (LCM) for biological products in Europe. The objective was to provide a comprehensive analysis of current practices and emerging trends to inform strategic investment decisions in this specialized sector.

BTHT APPROACH

After an in-depth consultation with the consulting firm and a clear understanding of the project’s goals, the BTHT team got to work. They reached out to top executives from the pharmaceutical industry and Contract Development and Manufacturing Organizations (CDMOs) known for their expertise in R&D LCM. These experts were selected for their deep industry knowledge and experience. The BTHT team organized a series of high-level expert calls, ensuring each conversation was both insightful and technically seamless.

OUTCOME

The BTHT team’s efforts provided the private equity firm with exceptional insights from leading pharma and CDMO executives. The quality of the information shared was outstanding, surpassing the client's expectations. The expert calls delivered critical perspectives on outsourcing trends, R&D strategies, and life cycle management practices, offering valuable guidance for making well-informed investment decisions. The client was particularly impressed by the depth and relevance of the insights, which proved essential for understanding the dynamic landscape of biological product R&D in Europe.